Navigation Links
NewCardio Announces New Client Services Team
Date:10/17/2008

Greg Sadowski named Senior VP, Client Services; Kathleen A. Walsh named VP, Product Management; Gilbert V. Molina named Director, Corporate Systems

Completes leadership for team to commercialize and support initial

application of NewCardio's platform technology

SANTA CLARA, Calif., Oct. 17 /PRNewswire-FirstCall/ -- NewCardio, Inc., (OTC Bulletin Board: NWCI) a cardiac diagnostic and services company, today announced the hiring of three key executives to complete the Company's client services team. Greg Sadowski joined NewCardio as Senior Vice President, Client Services. Kathleen A. Walsh joined as Vice President, Product Management. Gilbert V. Molina joined as Director, Corporate Systems.

Mr. Sadowski brings 11 years experience in the Clinical Research sector and a proven track record in rapidly creating new functional groups, business units and technical architectures from the ground up. He joins NewCardio from eResearchTechnology (eRT), where he most recently served on the Executive Management Team as Senior VP of eRT's new Electronic Patient Reported Outcomes (ePRO) business unit while retaining responsibilities as the company's senior executive for the Information Technology and Customer Care groups. Mr. Sadowski will be responsible for effectively preparing, delivering and supporting the NewCardio cardiovascular diagnostic technology solutions, to include the Professional Services, Information Technology, Customer Care and Quality Assurance groups.

Mrs. Walsh also joins NewCardio from eRT, bringing over 11 years of Corelab Management experience. As Vice-President, Project Management she was responsible for leading the Global Project Management department, the Online Reporting Services department and the Training Academy department. She was specifically responsible for developing, implementing and streamlining processes to maximize revenue while maintaining and enhancing client satisfaction. At NewCardio, Mrs. Walsh will be responsible for Product Management, working with both internal and external teams to effectively define and deliver the strategic cardiovascular diagnostic technology solutions that will be derived from the NewCardio 3Dimensional platform technology.

Mr. Molina is a proven IT manager with nine years experience working at diverse, fast-paced and rapidly-growing organizations. He brings a track record of working with diverse groups and managing complex, mission-critical projects. Most recently, he served as Manager, Information Technology where he oversaw IT Operations at eRT's headquarters. At NewCardio he will be responsible for developing and supporting the IT infrastructure, to include hardware, networks and corporate systems, required to support the strategic growth initiatives of the company.

Vincent Renz, NewCardio's President, commented, "I have worked closely with each of these three professionals and as such, have great respect for their capabilities and expertise in working together as a team to bring quality solutions to market. I'm excited to have them join NewCardio, providing a solid foundation for building a world class Client Services organization focused on working together for our customers. This represents a milestone event for NewCardio, as not only will this team prove instrumental in accelerating our commercialization efforts, but will also send a clear signal to our potential customers across the life sciences and health care industries of our commitment to providing stellar service and compelling value."

About NewCardio, Inc.

NewCardio is a cardiac diagnostic and services company focused on the development of a proprietary platform technology to provide higher accuracy to, and increase the value of, the standard 12-lead electrocardiogram (ECG). NewCardio's development-stage software and hardware products and services are intended to improve the diagnosis and monitoring of cardiovascular disease (CVD), as well as cardiac safety assessment of drugs under development. NewCardio's three-dimensional ECG platform is designed to reduce the time and expense involved in assessing cardiac status while increasing the ability to diagnose clinically significant conditions which were previously difficult to detect. For more information, visit http://www.newcardio.com.

Forward-Looking Statements

This press release contains forward-looking statements. Forward-looking statements include, but are not limited to, statements that express our intentions, beliefs, expectations, strategies, predictions or any other statements relating to our future activities or other future events or conditions. These statements are based on current expectations, estimates and projections about our business based on currently available information and assumptions made by management. Although we believe that the assumptions on which the forward-looking statements contained herein are based are reasonable, any of those assumptions could prove to be inaccurate given the inherent uncertainties as to the occurrence or nonoccurrence of future events. These statements are not guarantees of future performance and involve risks and uncertainties that are difficult to predict. Therefore, actual outcomes and results may, and are likely to, differ materially from what is expressed or forecasted in the forward-looking statements due to numerous factors, including the potential risks and uncertainties set forth in Item 1A of our Annual Report on Form 10-K/A (No. 2) for the year ended December 31, 2007 and relate to our business plan, our business strategy, development of our proprietary technology platform and our products, timing of such development, timing and results of clinical trials, level and timing of FDA regulatory clearance or review, market acceptance of our products, protection of our intellectual property, implementation of our strategic, operating and people initiatives, benefits to be derived from personnel and directors, ability to commercialize our products, our assumptions regarding cash flow from operations and cash on-hand, the amount and timing of operating costs and capital expenditures relating to the expansion of our business, operations and infrastructure, implementation of marketing programs, our key agreements and strategic alliances, our ability to obtain additional capital as, and when, needed, and on acceptable terms and general economic conditions specific to our industry, any of which could impact sales, costs and expenses and/or planned strategies and timing. We assume no obligation to, and do not currently intend to, update these forward-looking statements.

To join our email distribution please click this link: http://www.b2i.us/irpass.asp?BzID=1645&to=ea&s=0


'/>"/>
SOURCE NewCardio, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. CTG HealthCare Solutions Announces New EPIC Implementation Engagements
2. Apex Bioventures Announces Trust Investment Details
3. Warner Chilcott Announces Earnings Release Date and Conference Call for Third Quarter 2008 Financial Results
4. FairWarning(R) Announces New Privacy Surveillance Software Release
5. Environmental Tectonics Corporations Sterilization Systems Group Announces the Receipt of Three New Contracts
6. Cardiogenesis Announces Successful Educational Symposium Targeted at Cardiologists at the TCT Meeting in Washington, D.C.
7. Boston Scientific Announces Drug-Eluting Stent Market Share Estimates for September and Third Quarter
8. Gen-Probe Announces Webcasts of Three Upcoming Investor Events
9. Texas Back Institute Announces Nine for Your Spine for National Spine Health Day - October 16
10. CoreValve Announces That More Than 1,800 High-Risk Patients Have Been Treated with its ReValving System for Percutaneous Aortic Valve Replacement (PAVR) : Highly encouraging registry data also presented at TCT 2008
11. RF Technologies(R) Announces Code Alert(R) Integrated Care Management Solution
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/16/2017)... ... January 16, 2017 , ... Date ... http://www.ageofautism.com/legal , Sharon Kleyne, America’s leading water educator, researcher and advocate ... syndicated radio program, The Sharon Kleyne Hour Power of Water, Global Climate Change ...
(Date:1/16/2017)... Francisco, CA (PRWEB) , ... January 16, 2017 , ... ... incorporation of iTero Element, the latest in 3-D scanning device which is capable of ... of the latest advances in dentistry, such as CAD CAM restorations , in ...
(Date:1/15/2017)... ... January 15, 2017 , ... ... is a program that strives to better communities around the world by offering ... It also provides the opportunity for team members to become involved in a ...
(Date:1/15/2017)... (PRWEB) , ... January 15, 2017 , ... ... choice of best physicians in eight Bay Area counties for 2017. Almost 1,000 ... healthcare research company managing the award process. Results were announced the magazine’s ...
(Date:1/14/2017)... ... January 14, 2017 , ... Healthy ... expanding line of activated charcoal products. With more and more people opting to ... products according to how they cater to specific needs. , Moody Zook focused ...
Breaking Medicine News(10 mins):
(Date:1/16/2017)... India , January 16, 2017 According to a ... Global Opportunity Analysis and Industry Forecast, 2014 - 2022," the global antioxidants market ... 2022, registering a CAGR of 6.42% during the forecast period. In the natural ... global volume in 2015. Continue Reading ... ...
(Date:1/16/2017)... Jan. 16, 2017  Today, Analytics 4 Life (A4L), ... announced its expansion into JLABS @ Toronto ... science incubators. As a resident in the space, A4L ... device development and commercialization expertise. JLABS @ ... innovation center that provides a flexible environment for start-up ...
(Date:1/15/2017)... Le conseil d,administration de SurgaColl Technologies ... pour la régénération de tissus humains, annonce la nomination de ... avec effet immédiat. ... Bill est un dirigeant expérimenté à l,international dans ... gestion générale et de direction au sein de sociétés internationales ...
Breaking Medicine Technology: